Recent Advances in Cystic Fibrosis Research - S. Karger - książka wyd. 1979

Opis

More recently, a new class of therapeutics called CFTR modulators, small molecule agents that potentiate CFTR or restore diminished protein levels at the cell surface, have been developed. These therapeutics directly address the functional protein defects that cause cystic fibrosis.